Literature DB >> 2689303

Ultrasound findings in uterine mixed müllerian sarcomas and endometrial stromal sarcomas.

B Cacciatore1, P Lehtovirta, T Wahlström, P Ylöstalo.   

Abstract

Sonographic findings in five cases of mixed mullerian tumors and two cases of endometrial stromal sarcoma which were evaluated before surgery for staging are reviewed. Assessment of myometrial invasion was in agreement with surgical findings in five cases; in the two other cases invasion was overestimated. The echo pattern of these tumors presented some peculiarities. In five patients, four with mixed mullerian tumors and one with endometrial stromal sarcoma, a heterogenous pattern with high-intensity and hypoechoic areas scattered in the myometrium was seen. In the other two cases the sonographic picture was indistinguishable from that of leiomyomas. Sonography is an accurate imaging technique for preoperative staging of uterine sarcomas. If an heterogenous echo pattern of the uterus as described is found at sonography, sarcoma should be suspected and laparotomy performed urgently.

Entities:  

Mesh:

Year:  1989        PMID: 2689303     DOI: 10.1016/0090-8258(89)90065-6

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  Sonographic findings of uterine endometrial stromal sarcoma.

Authors:  Jeong-Ah Kim; Myung Sook Lee; Jong-Sun Choi
Journal:  Korean J Radiol       Date:  2006 Oct-Dec       Impact factor: 3.500

Review 2.  Ultrasound-Guided Trans-Uterine Cavity Core Needle Biopsy of Uterine Myometrial Tumors to Differentiate Sarcoma from a Benign Lesion-Description of the Method and Review of the Literature.

Authors:  Maciej Stukan; Piotr Rutkowski; Jeremy Smadja; Sylvie Bonvalot
Journal:  Diagnostics (Basel)       Date:  2022-05-29

3.  Endometrial stromal sarcomas: a retrospective analysis of 28 patients, single center experience for 20 years.

Authors:  Eun Ji Nam; Jae Wook Kim; Dae Woo Lee; Si Young Jang; Jong Wook Hong; Young Tae Kim; Jae Hoon Kim; Sunghoon Kim; Sang Wun Kim
Journal:  Cancer Res Treat       Date:  2008-03-31       Impact factor: 4.679

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.